Skip to main content

Mobocertinib Succinate

Placeholder slot
 (MOH-boh-SER-tih-nib SUK-sih-nayt)

This page contains brief information about mobocertinib succinate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA label information for this drug is available at DailyMed.

Use in Cancer

Mobocertinib succinate is approved to treat:

Mobocertinib succinate is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that it provides a clinical benefit in these patients.

Mobocertinib succinate is also being studied in the treatment of other conditions.

More About Mobocertinib Succinate

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Mobocertinib Succinate - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: